“This partnership with Eurobio Scientific marks an important milestone for Gelomics as we continue to expand our global presence. We are confident that Eurobio’s expertise and strong connections in the French market will allow us to better serve researchers and institutions committed to advancing drug development and biomedical innovation. Together, we aim to provide more accessible, ethical, and predictive alternatives to traditional methods, accelerating progress in the life sciences community.”
Dr Christoph Meinert, CEO of Gelomics
“We are thrilled about our new partnership with Gelomics, which enables us to offer innovative, ethical, and high-quality products to researchers working with 3D cell cultures. This new product range is a natural extension of our portfolio, and we are confident in the successful launch of these products in France, thanks to our expertise in cell culture and strong presence in the field.”
Dejan Drljaca, CCO of Eurobio Scientific.
About Gelomics
Gelomics is dedicated to revolutionising drug development and biomedical research by enabling the cultivation of human tissues in vitro. Our mission is to accelerate therapeutic breakthroughs by providing scientists with ethical, cost-effective, and predictive alternatives to animal testing. Learn more about Gelomics’ innovative products and access our product catalogue: www.gelomics.com
About Eurobio Scientific
Eurobio Scientific is a fully integrated French leader in the field of in-vitro diagnostics. Formed through the acquisitions of Ingen by Exonhit in 2012 and Eurobio in 2017, the company specializes in the discovery, development, and commercialization of specialty diagnostic solutions. In addition to diagnostics, Eurobio Scientific offers a comprehensive range of products for life science research, supporting researchers and
healthcare providers with cutting-edge innovations across Europe. For more information about Eurobio Scientific please visit www.eurobio-scientific.com.
Komentar